Christopher R. Loose, Chief Scientific Officer at Frequency Therapeutics, Inc. (FREQ), sold 8,000 shares at $40.00 ($325K) on 2020-12-17, disclosed to the SEC on 2020-12-17.
Open-market sale of $325k FREQ by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.00 | 6,000 | $240K | 73.8% |
| 2 | $42.50 | 2,000 | $85K | 26.2% |
| Total | $40.63 avg | 8,000 | $325K | 100% |
| Filing → |
| FREQ | SELL | 2023-07-25 | $2K | — | Filing → |
| FREQ | SELL | 2023-07-21 | $2K | — | Filing → |
| FREQ | SELL | 2023-07-19 | $2K | — | Filing → |